Introduction <p>This study compared the calculated vancomycin area under the curve (AUC<sub>0–24</sub>)&#xa0;using trapezoidal and non-trapezoidal first-order pharmacokinetic equations.</p> Methods <p>This retrospective observational study included adult patients with documented MRSA bacteremia who received ≥ 48 h of intravenous vancomycin and had two consecutive serum levels after the first dose. AUC<sub>0–24</sub> was calculated using trapezoidal and non-trapezoidal equations. Correlation and agreement between methods were assessed using Pearson’s correlation coefficient (<i>r</i>) and Bland–Altman plots. Significant predictors (<i>p</i> &lt; 0.05) from simple linear regression were included in a multiple linear regression model to evaluate their impact on AUC<sub>0–24</sub> for both methods.</p> Results <p>Fifty-two patients were included. The median age was 63 years (interquartile range [IQR]: 50–73), and the median vancomycin clearance was 4 l/h (IQR: 2–6). Median vancomycin AUC<sub>0-24</sub> was 399 mg∙h/l (IQR: 257–674) for the trapezoidal method and 572 mg∙h/l (IQR: 466–807) for the non-trapezoidal method. There was a strong correlation between the methods (<i>r</i> = 0.87 [95% CI, 0.79–1]; <i>P</i> &lt; 0.01), but Bland–Altman analysis showed poor agreement, with a bias of –&#xa0;198 mg∙h/l and 95% limits of agreement from –&#xa0;482 to 86 mg∙h/l. In multiple linear regression, total daily dose and vancomycin clearance were independent predictors of AUC<sub>0–24</sub> for both methods, with a stronger impact on non-trapezoidal AUC<sub>0-24</sub> (adjusted <i>R</i><sup>2</sup> = 0.70) than trapezoidal AUC<sub>0–24</sub> (adjusted <i>R</i><sup>2</sup> = 0.59).</p> Conclusions <p>Trapezoidal and non-trapezoidal equations are not interchangeable for estimating vancomycin AUC<sub>0–24</sub>. The trapezoidal method consistently results in lower AUC<sub>0–24</sub> estimates than the non-trapezoidal method.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Are All Pharmacokinetic Equations Created Equal? A Comparative Analysis of Trapezoidal and Non-Trapezoidal Methods for Estimating Day 1 Area Under the Curve in Adult Hospitalized Patients with Staphylococcus aureus Bacteremia

  • Abdulwhab Shremo Msdi,
  • Alireza Fakhri Ravari,
  • Jacinda C. Abdul-Mutakabbir,
  • Karen K. Tan

摘要

Introduction

This study compared the calculated vancomycin area under the curve (AUC0–24) using trapezoidal and non-trapezoidal first-order pharmacokinetic equations.

Methods

This retrospective observational study included adult patients with documented MRSA bacteremia who received ≥ 48 h of intravenous vancomycin and had two consecutive serum levels after the first dose. AUC0–24 was calculated using trapezoidal and non-trapezoidal equations. Correlation and agreement between methods were assessed using Pearson’s correlation coefficient (r) and Bland–Altman plots. Significant predictors (p < 0.05) from simple linear regression were included in a multiple linear regression model to evaluate their impact on AUC0–24 for both methods.

Results

Fifty-two patients were included. The median age was 63 years (interquartile range [IQR]: 50–73), and the median vancomycin clearance was 4 l/h (IQR: 2–6). Median vancomycin AUC0-24 was 399 mg∙h/l (IQR: 257–674) for the trapezoidal method and 572 mg∙h/l (IQR: 466–807) for the non-trapezoidal method. There was a strong correlation between the methods (r = 0.87 [95% CI, 0.79–1]; P < 0.01), but Bland–Altman analysis showed poor agreement, with a bias of – 198 mg∙h/l and 95% limits of agreement from – 482 to 86 mg∙h/l. In multiple linear regression, total daily dose and vancomycin clearance were independent predictors of AUC0–24 for both methods, with a stronger impact on non-trapezoidal AUC0-24 (adjusted R2 = 0.70) than trapezoidal AUC0–24 (adjusted R2 = 0.59).

Conclusions

Trapezoidal and non-trapezoidal equations are not interchangeable for estimating vancomycin AUC0–24. The trapezoidal method consistently results in lower AUC0–24 estimates than the non-trapezoidal method.